Ganweikang Tablet Attenuates the NAFL and NASH by Inhibiting Inflammation, Apoptosis and Enhancing Fatty Acid Oxidation Through Inhibiting NFκB and caspase8 and Activating PPARα. Here, PPARA is linked to non-alcoholic fatty liver.